to study the result of capsule M 11 on diabetes type 2 patients

Phase 1

• Conditions: Health Condition 1: null- diabetes mellitus type 2

• Registration Number: CTRI/2018/04/013378
• Lead Sponsor: self

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

(a) Patients having clinical features of Madhumeha(DM type II)

(b) Patients between the age group of 18-60 years of either sex.

Exclusion Criteria

1. Patients of Sahaja Madhumeha [IDDM]

2. Patient of type II DM who are on Insulin therapy

3. DM with complications.

4. Diabetes insipidus

5. Drug induced DM.

6. Age below 18 and above 60 years

7. Diabetes mellitus due to other hormonal disturbances like Phaeochromocytoma, Acromegaly, Thyrotoxicosesetc

8. Diabetes due to side-effects of drugs:

a)Diuretics (thiazide groups) b) steroid

9. FBS [ >250mg/dl]

10. PPBS [ >350mg/dl]

11. DM with coronary artery diseases

12. Uncontrolled DM

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
patients who were not taking any hypoglycemic drugs showed good resultsTimepoint: 15 days

Secondary Outcome Measures

Name	Time	Method
symptomatic relief in patients recieving drugTimepoint: 15 days